A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

Original Article from The New England Journal of Medicine -- A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan ...

... The New England Journal of Medicine -- A Trial of Three Regimens for Primary Amyloidosis: ... ABSTRACT. Background Primary systemic amyloidosis is an uncommon disease characterized by the ...

BACKGROUND: Primary systemic amyloidosis is an uncommon disease characterized by the accumulation in vital organs of a fibrillar protein consisting of monoclonal light chains.

PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to ...

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan ... Response rates and survival in primary systemic amyloidosis. Blood. 1991;77: 257-262. [Abstract/ ...

... trial of three regimens for primary amyloidosis ... Abstract] Skinner M, Anderson J, Simms R, et al.: Treatment of 100 patients with primary amyloidosis: a randomized trial of ...

Image Bank Education Program Book ASH-SAP Abstract Search ... A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and ...

Blood. 2004;103: 2936-2938. [Abstract/ Free Full Text] Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and ...

Blood 2006;108:2520-30. [Abstract/ Free Full Text] Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, et al. A trial of three regimens for primary amyloidosis: colchicine ...